{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-001928","form_type":"8-K","ticker":"NRC","cik":"0000070487","company_name":"NRC HEALTH","filed_at":"2025-01-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.099267+00:00","generated_at":"2026-05-27T09:42:04.353923+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NRC Q4 revenue $36.9M, EPS $0.28; CTO Louvion resigns","bullets":["Q4 revenue $36.9M vs $38.0M YoY; diluted EPS $0.28 vs $0.36.","Net indebtedness $58.5M; total recurring contract value $133.2M at Dec 31, 2024.","Returned $10.1M to shareholders: $7.3M in stock repurchases (393k shares) plus $0.12/share dividend.","Chief Product Technology Officer Chrisophe Louvion resigned effective Jan 27, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-001928","json":"https://secwatch.observer/filing/0001437749-25-001928.json","markdown":"https://secwatch.observer/filing/0001437749-25-001928.md","text":"https://secwatch.observer/filing/0001437749-25-001928.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70487/000143774925001928/0001437749-25-001928-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70487/000143774925001928/nrc20250124_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T09:42:04.353923+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}